Shares of Vivos Inc. (OTCMKTS:RDGL – Get Free Report) dropped 2.2% during mid-day trading on Friday . The company traded as low as $0.11 and last traded at $0.12. Approximately 971,878 shares changed hands during trading, a decline of 22% from the average daily volume of 1,244,290 shares. The stock had previously closed at $0.12.
Vivos Trading Down 2.2 %
The company’s 50-day moving average is $0.15 and its 200 day moving average is $0.16. The firm has a market cap of $51.13 million, a PE ratio of -12.17 and a beta of 1.08.
About Vivos
Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.
Further Reading
- Five stocks we like better than Vivos
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- From PACs to Portfolios: Billionaire Bets and Investor Reactions
- Most active stocks: Dollar volume vs share volume
- AppLovin Stock Quadruples: What’s Behind the Bullish Sentiment?
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Battle of the Retailers: Who Comes Out on Top?
Receive News & Ratings for Vivos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivos and related companies with MarketBeat.com's FREE daily email newsletter.
